Abstract: In this paper, we report on the evaluation methodology developed to support the experimental plan to assess the big data prototype developed under the umbrella of the datAcron project. The ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Hoth Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative, impactful, and ground-breaking treatments with a goal to improve patient quality of life. We are a ...

Hoth Therapeutics has shared phase 2 results on its treatment of EGFR inhibitor-induced skin toxicities, ticking off another milestone for a candidate designed to complement cancer therapies. The open ...

NEW YORK, Jan. 15, 2026 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing therapies for serious and underserved conditions, today announced ...

Datacrons are one of those Galaxy of Heroes systems that can feel equal parts “strategic depth” and “please stop adding homework.” Now Capital Games is changing how they work — and it’s not a small ...

Heaven gained a special angel with the passing of Reda Lafave Hoth, Dec. 30 at her daughter’s home in South Carolina where she resided. Reda was born April 15, 1927 in Churbusco, NY to the late ...

Heaven gained a special angel with the passing of Reda Lafave Hoth, Dec. 30 at her daughter’s home in South Carolina where she resided. Reda was born April 15, 1927 in Churbusco, NY to the late ...

Hoth Therapeutics filed patents to address skin toxicities from cancer therapies, focusing on HT-001's neurogenic and inflammatory pathway targeting. The patents aim to secure intellectual property ...

If your Datacrons felt like they went through a few too many hyperspace jumps this week, you’re not imagining it. Star Wars: Galaxy of Heroes has run into a significant Datacron issue tied to the ...

NEW YORK - Hoth Therapeutics, Inc. (NASDAQ:HOTH) provided an update on Wednesday on its therapeutic pipeline, highlighting progress across four development programs. The clinical-stage ...

NEW YORK - Hoth Therapeutics, Inc. (NASDAQ:HOTH) has been accepted into the NVIDIA Connect Program, the clinical-stage biopharmaceutical company announced Thursday. The biotech firm, currently valued ...